Arkema announced that it will increase its global polyamide 12 polymer production capacity by 25% as a supplement to its key project bio-based polyamide 11 (PA11) to meet its customers' strong demand in Asia.
Arkema's investment plan announced this time will increase the production capacity of 25% of PA12 polymer under the Rilsamid® brand. The new capacity will be started at Arkema's production base in Changshu, China and production is expected by mid-2020. With this latest investment plan , Arkema will continue to strengthen its specialty polyamide business in three major global regions - Europe, North America and Asia.
Arkema's tens of millions of euros this investment, will support the cable protection, automotive lightweight (metal substitutes), high-performance sports shoes (running shoes, football shoes, etc.) and other high-growth applications, and consumer electronics in this development Strong demand in the field.It is expected that these applications in the medium-term market in Asia will grow at an average annual rate of more than 7%.
"With this latest project, the Arkema Specialty Polyamide business will further strengthen its industry position in Asia, its business level and its research and development capabilities, and fulfill its commitment to providing localized services to its global customers. Seeing our rapid growth into a local It is also very exciting for our customers to become a world-class manufacturing company based in Asia and have considerable R & D and service capabilities. "